Synergistic protection of chilled canine spermatozoa by apigenin and N-acetylcysteine amide through enhanced antioxidant defense and mitochondrial function Authors: Soroush Heidari, Ali Soleimanzadeh, Reza Mirzaie Published: 2026 ABSTRACT AbstractObjectivesSemen preservation is a critical aspect of assisted reproductive technologies in canine breeding programs; however, oxidative stress during chilled storage negatively affects sperm quality by impairing motility, membrane integrity, and mitochondrial function. This study investigated the protective effects of apigenin and N-acetylcysteine amide (NACA), individually and in combination, on the quality, antioxidant defense system, and mitochondrial activity of canine spermatozoa stored at 5 °C for 72 h.MethodsSemen samples collected from five healthy mixed-breed dogs with proven fertility were pooled and diluted in a Tris–egg yolk extender supplemented with apigenin (0.2 or 0.4 mM), NACA (0.5 or 1 mM), or a combination of both (0.4 mM apigenin + 1 mM NACA). Sperm motility, membrane functionality, viability, DNA integrity, oxidative/antioxidant biomarkers, and mitochondrial parameters were evaluated at 0, 24, 48, and 72 h.ResultsBoth antioxidants significantly improved all parameters compared with the control, with the combined treatment exhibiting the most pronounced and synergistic effects: motility and kinematic parameters approximately twofold higher, antioxidant enzyme activities markedly enhanced, lipid/protein oxidation reduced, and mitochondrial integrity and ATP production preserved after 72 h.ConclusionsIn conclusion, the synergistic combination of apigenin and N-acetylcysteine amide significantly improves the quality and longevity of chilled canine spermatozoa, offering a promising strategy for optimizing semen extenders in canine breeding programs.Keywords: Apigenin, N-acetylcysteine amide, Canine semen, Chilled storage, Oxidative stress, Mitochondrial function, Synergistic effect Introduction Semen preservation is a cornerstone of assisted reproductive technologies in canine breeding programs, enabling artificial insemination (AI) and the transfer of genetic material across geographical and temporal boundaries without the logistical challenges and health risks of transporting live animals [1]. Chilled storage at approximately 5 °C is widely used for short-term preservation of canine semen, maintaining viability for 3–5 days. However, such chilled storage can induce structural and functional sperm damage, although to a lesser extent than cryopreservation and thawing [2–4]. Spermatozoa are particularly susceptible to reactive oxygen species (ROS) due to their high content of polyunsaturated fatty acids (PUFAs) in the plasma membrane and limited cytoplasmic antioxidant capacity [2, 5]. ROS generation during cooling and storage occurs via multiple pathways, including mitochondrial electron transport chain leakage and NADPH oxidase activity, and is exacerbated by the dilution of seminal plasma during extender addition, which reduces endogenous antioxidants and alters the oxidative–antioxidant balance, as reported in ram semen and other mammalian species [6–8]. Antioxidant supplementation of semen extenders has been extensively investigated across mammalian species to counteract ROS-mediated damage during chilled storage. In cattle, catalase (CAT), superoxide dismutase (SOD), and glutathione (GSH) supplementation has improved motility, viability, and reduced lipid peroxidation [9]. In goats, GSH and vitamin E enhanced progressive motility and membrane integrity. In sheep, melatonin and resveratrol preserved kinematic parameters and mitochondrial function over extended chilled periods. In horses, carnitine and taurine supported motility and reduced oxidative stress during cooling. In canines, CAT, lycopene, and various non-enzymatic antioxidants have reduced ROS levels and improved semen quality during chilled storage [4, 9–11]. Canine spermatozoa possess intrinsic defense systems, including enzymatic antioxidants such as superoxide dismutase (SOD) and glutathione peroxidase (GPx), along with catalase, and non-enzymatic antioxidants like reduced glutathione and vitamins C and E, to combat lipid peroxidation, consistent with observations in various mammalian species [4]. Exogenous antioxidants such as N-acetyl-L-cysteine (NAC) have been shown to enhance sperm quality by directly scavenging ROS and boosting intracellular glutathione levels [12, 13]. N-acetylcysteine amide (NACA), a derivative of NAC with enhanced cellular permeability and bioavailability, has demonstrated superior protective effects on sperm parameters across various species, including dogs [12], roosters [14], goats [15], and in human studies of infertile men [16]. In parallel, phytochemical compounds with potent antioxidant properties have garnered attention for semen preservation. Apigenin, a naturally occurring flavonoid, exhibits strong free radical-scavenging activity and low toxicity, protecting sperm from oxidative damage and maintaining mitochondrial function [17, 18]. Studies in various species, including bull semen [19] and human spermatozoa [20], have demonstrated that apigenin supplementation preserves motility, mitochondrial membrane potential, and ATP content during storage or cryopreservation. The protective mechanisms of apigenin and NACA converge on reducing ROS production, maintaining mitochondrial integrity, and stabilizing energy metabolism, thereby preserving sperm viability and fertilizing potential during chilled storage. Despite these promising findings, the combined protective effect of apigenin and NACA in canine semen has not been systematically evaluated. Based on their complementary mechanisms—apigenin primarily acting as a mitochondrial-targeted radical scavenger and NACA enhancing intracellular antioxidant defenses—it is hypothesized that their combination could exert synergistic protection during liquid storage at 5 °C. Therefore, the present study aims to investigate the effects of apigenin and N-acetylcysteine amide, both individually and in combination, on canine sperm quality, antioxidant defense systems, and mitochondrial function during liquid storage at 5 °C. By assessing parameters such as motility, membrane integrity, oxidative stress markers, and mitochondrial bioenergetics, this study seeks to provide novel insights into optimizing semen extenders for improved preservation of functional spermatozoa in canine breeding programs. Materials and methods Ethical approval and animals This study was conducted with ethical approval from the Animal Ethics Committee of the University of Urmia (IR-UU-AEC-3/45). Five clinically healthy mixed-breed male dogs aged 3–5 years with proven fertility were used. Before the start of the experiment, the general health status of all animals was examined by a veterinarian, including physical examination, assessment of body condition score, rectal temperature, heart and respiratory rates, mucous membrane color, lymph node palpation, and basic hematological and biochemical profiles to confirm absence of systemic disease or reproductive pathology. Only ejaculates showing initial sperm quality of more than 70% total motility and more than 80% viability were included in the study. Semen collection and pooling Ejaculates were obtained twice weekly by manual stimulation (using digital pressure applied to the bulbus glandis following teasing with an estrous female in the presence of the operator to elicit erection and ejaculation), with at least three days between collections to avoid depletion effects [12]. Each ejaculate consisted of three fractions (pre-sperm, sperm-rich, and post-sperm), and only the sperm-rich fraction was used for further evaluation. Semen samples were collected into sterile graduated tubes and evaluated immediately for macroscopic characteristics (volume, color, and contamination). Sperm concentration was determined using a Bürker counting chamber after dilution in 0.85% NaCl [21]. Only ejaculates exhibiting ≥ 70% total motility and ≥ 80% viability were included in the study [22]. To minimize individual variability, ejaculates from the five dogs (one ejaculate from each dog per collection day) were pooled for each biological replicate, and the pooled sample was immediately divided into the treatment groups. Collections were performed twice weekly for four weeks, resulting in a total of 40 ejaculates (8 per dog) across the study period, but five independent biological replicates were conducted using pools prepared on different collection days. All experiments were performed in five independent biological replicates [10, 23, 24]. Extender composition and preparation The basic extender was prepared according to the Tris–egg yolk formulation, composed of Tris (3.028 g), citric acid (1.675 g), fructose (1.25 g), egg yolk (20%, v/v), and penicillin (1000 IU/mL) + streptomycin (1 mg/mL) in 100 mL of distilled water [22]. This penicillin-streptomycin combination (Pen-Strep) was included as a broad-spectrum antibiotic to prevent bacterial contamination during chilled storage, a standard practice in canine semen extenders [22, 24]. The pH and osmolarity were adjusted to 6.8 and 300 mOsm/kg, respectively. All solutions were prepared with sterile distilled water and filtered through a 0.22-µm filter. Antioxidants were added to the extender immediately before use: apigenin (0.2 or 0.4 mM), NACA (0.5 or 1 mM), or the combination (0.4 mM apigenin + 1 mM NACA). These concentrations were selected based on preliminary dose-response experiments in our laboratory and published literature demonstrating optimal protective effects at these levels in canine and other mammalian species during chilled storage or cryopreservation [24]. Sperm motility assessment Sperm motility was evaluated using a Computer-Assisted Sperm Analysis system (CASA; Test Sperm 3.2; Videotest, St. Petersburg, Russia). Settings were optimized for canine sperm: frame rate 60 Hz, frames acquired 30–60, minimum contrast 85, minimum cell size 6 pixels; velocity thresholds: motile VAP > 25 μm/s, progressive motility VAP > 50 μm/s and STR > 80%; kinematic parameters included VCL, VSL, VAP, ALH, BCF, LIN, STR. Semen was diluted to approximately 50 × 10⁶ sperm/mL and analyzed in a Makler counting chamber (fixed depth of 10 μm) at 37 °C. This dilution ensured clear spatial separation of sperm heads (typically 50–80 spermatozoa per field, never exceeding 100) to avoid overlap, track loss, or merging by the CASA algorithms, as required for accurate tracking. After pilot testing confirmed reliable tracking without excessive artifacts, approximately 200 spermatozoa per sample were analyzed in at least five randomly selected microscopic fields [24]. Sperm viability and membrane functionality Viability 10 µL semen was mixed with 30 µL eosin–nigrosin stain (0.5% eosin Y, 10% nigrosin in isotonic citrate buffer), smeared on a warm slide, air-dried, and examined under bright-field microscopy at 1000× magnification. Approximately 200 spermatozoa were evaluated per sample in at least five randomly selected microscopic fields (viable: unstained/white head; dead: pink/red head) [24]. Membrane functionality (hypo-osmotic swelling test, HOST) 10 µL semen was incubated in 90 µL hypo-osmotic solution (7.35 g sodium citrate + 13.5 g fructose per liter, 150 mOsm/kg) for 30 min at 37 °C. Approximately 200 spermatozoa were evaluated per sample in at least five randomly selected microscopic fields under phase-contrast microscopy (swollen/coiled tails = functional membrane) [24]. DNA integrity (acridine orange staining) 2 µL semen was mixed with 20 µL acridine orange solution, incubated for 5 min at room temperature, and examined under fluorescence microscopy (excitation 460–490 nm, emission > 520 nm). Approximately 200 spermatozoa were evaluated per sample in at least five randomly selected microscopic fields (green fluorescence = intact DNA; red/orange = fragmented DNA) [24]. Preparation of seminal plasma for biochemical analyses After centrifugation of semen samples at 800 × g for 10 min, the supernatant (seminal plasma) was carefully collected, avoiding any residual spermatozoa, and stored at − 20 °C until biochemical analyses. To ensure complete removal of sperm cells and prevent interference in biochemical measurements, an additional high-speed centrifugation step (12,000 × g for 5 min at 4 °C) was performed on the supernatant prior to analysis, as recommended in standard protocols for seminal plasma biomarker assays. Antioxidant/oxidative stress biomarkers The following parameters were measured in seminal plasma using commercial colorimetric assay kits, following the manufacturer’s instructions. All assays were performed in duplicate on a microplate reader (appropriate wavelengths as specified in each kit protocol), and results were normalized to protein content or sample volume where applicable [24]. Total antioxidant capacity (TAC) Determined by the ferric reducing antioxidant power (FRAP) method using the Naxifer™ Total Antioxidant Capacity Assay Kit (Navand Salamat Company, Urmia, Iran). Antioxidant enzymes ◦ Glutathione peroxidase (GPx) activity using the Nagpix™ Glutathione Peroxidase (GPx) Activity Assay Kit (Navand Salamat Company, Urmia, Iran). ◦ Glutathione peroxidase (GPx) activity using the Nagpix™ Glutathione Peroxidase (GPx) Activity Assay Kit (Navand Salamat Company, Urmia, Iran). ◦ Superoxide dismutase (SOD) activity using the Nasdox™ Superoxide Dismutase Assay Kit (Navand Salamat Company, Urmia, Iran). ◦ Superoxide dismutase (SOD) activity using the Nasdox™ Superoxide Dismutase Assay Kit (Navand Salamat Company, Urmia, Iran). ◦ Catalase (CAT) activity using the appropriate Catalase Activity Assay Kit (Navand Salamat Company, Urmia, Iran; Nactaz™). ◦ Catalase (CAT) activity using the appropriate Catalase Activity Assay Kit (Navand Salamat Company, Urmia, Iran; Nactaz™). Non-enzymatic antioxidants ◦ Reduced glutathione (GSH) using the NarGul™ Glutathione Assay Kit-GSH (Navand Salamat Company, Urmia, Iran). ◦ Reduced glutathione (GSH) using the NarGul™ Glutathione Assay Kit-GSH (Navand Salamat Company, Urmia, Iran). ◦ Total thiol groups (TSH) using the Natothiol™ Total Thiol Assay Kit (Navand Salamat Company, Urmia, Iran). ◦ Total thiol groups (TSH) using the Natothiol™ Total Thiol Assay Kit (Navand Salamat Company, Urmia, Iran). Oxidative stress biomarkers ◦ Malondialdehyde (MDA) as a marker of lipid peroxidation using the Nalondi™ Lipid Peroxidation Assay Kit (Navand Salamat Company, Urmia, Iran). ◦ Malondialdehyde (MDA) as a marker of lipid peroxidation using the Nalondi™ Lipid Peroxidation Assay Kit (Navand Salamat Company, Urmia, Iran). ◦ Hydrogen peroxide (H₂O₂) using a commercial Hydrogen Peroxide/Peroxide Assay Kit (Cell Biolabs, USA; colorimetric method, catalog/reference B7CB06D3 or equivalent OxiSelect™ series). ◦ Hydrogen peroxide (H₂O₂) using a commercial Hydrogen Peroxide/Peroxide Assay Kit (Cell Biolabs, USA; colorimetric method, catalog/reference B7CB06D3 or equivalent OxiSelect™ series). ◦ Protein carbonyl content using the Protein Carbonyl Assay Kit (Karmania Pars Gene, Iran; CAT: KPG-CPA). ◦ Protein carbonyl content using the Protein Carbonyl Assay Kit (Karmania Pars Gene, Iran; CAT: KPG-CPA). All measurements were conducted according to the kit-specific protocols, with standard curves prepared for each run to ensure accuracy and reproducibility. Mitochondrial function and energy metabolism Mitochondrial membrane potential (MMP) was assessed using JC-1 fluorescent dye (Thermo Fisher Scientific, USA). Sperm samples were incubated with JC-1 (2 µM final concentration) for 15–20 min at 37 °C in the dark. Samples were then examined under a fluorescence microscope (excitation at 488 nm; emission filters: green monomers ~ 530 nm bandpass, orange-red J-aggregates ~ 590 nm longpass). Spermatozoa with high MMP exhibited orange-red fluorescence (J-aggregates), while those with low/depolarized mitochondria showed green fluorescence (monomers). Approximately 200 spermatozoa were evaluated per sample in at least five randomly selected microscopic fields [21]. Intracellular ATP levels were quantified using a luciferin–luciferase-based ATP detection kit (Sigma-Aldrich, USA) according to the manufacturer’s protocol. Luminescence was measured on a microplate reader, and ATP concentrations were calculated from a standard curve (expressed as nmol/10⁸ cells) [10, 23]. Oxygen consumption rate (OCR) was determined using a Clark-type oxygen electrode at 37 °C. While this method provides reliable comparative whole-cell respiration rates, high-resolution respirometry could provide more detailed insights into mitochondrial complex-specific activity in future studies. Measurements were performed on fresh or chilled sperm suspensions, with OCR expressed as pmol O₂/min/10⁶ cells [10, 23]. Statistical analysis All data were analyzed using SPSS software (version 27.0; IBM Corp., USA). Two-way ANOVA (factors: treatment and storage time) was used to analyze the data, followed by Tukey’s post hoc test to identify significant differences between groups [23, 25]. Percentage data were arcsine-transformed prior to analysis to meet the assumptions of normality. Differences were considered statistically significant at p < 0.05. Results The results presented in Table 1 demonstrate that both total motility (TM) and progressive motility (PM) of canine spermatozoa declined significantly (p < 0.05) during storage up to 72 h in all treatment groups; however, the rate of decline varied depending on the supplementation of apigenin and N-acetylcysteine amide (NACA). At 0 h, no significant differences were observed among treatments, indicating that neither antioxidant affected the initial motility of fresh semen. From 24 h onwards, spermatozoa preserved with combined apigenin + NACA exhibited significantly higher TM and PM compared with the control and single-antioxidant groups. In particular, the combination of 0.4 mM apigenin with 1 mM NACA maintained the highest motility values throughout storage, with TM and PM remaining approximately 1.8- and 2-fold higher, respectively, than the control at 72 h. These findings suggest a synergistic protective effect of apigenin and NACA against cold-storage-induced oxidative stress, likely through stabilization of sperm plasma membrane integrity and mitochondrial function, thereby enhancing sperm longevity and overall semen quality during extended preservation. Table 1Motility parameters of chilled canine semen stored for up to 72 h after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD)AnalysisStorage (h)ControlA-0.2 mMA-0.4 mMNACA-0.5 mMNACA-1 mMA-0.2 mM + NACA-0.5 mMA-0.4 mM + NACA-1 mMA-0.2 mM + NACA-1 mMA-0.4 mM + NACA-0.5 mMTotal Motility (TM, %)083.45 ± 1.56aA85.67 ± 1.34aA86.89 ± 1.45aA84.23 ± 1.67aA85.12 ± 1.56aA87.34 ± 1.23aA88.56 ± 1.45aA87.78 ± 1.34aA88.01 ± 1.56aA2462.78 ± 1.89bB64.56 ± 1.45bB66.78 ± 1.56bB63.89 ± 1.78bB65.34 ± 1.67bB83.45 ± 1.34bA84.67 ± 1.56bA82.90 ± 1.45bA83.12 ± 1.67bA4854.23 ± 2.12cC57.89 ± 1.67cC60.12 ± 1.78cC56.45 ± 1.89cC58.78 ± 1.78cC68.23 ± 1.45cA70.45 ± 1.67cA67.56 ± 1.56cA69.01 ± 1.78cA7232.89 ± 2.34dC35.67 ± 1.89dC38.45 ± 2.01dC34.12 ± 2.12dC36.89 ± 2.01dC57.89 ± 1.56dA59.78 ± 1.78dA56.34 ± 1.67dA58.23 ± 1.89dAProgressive Motility (PM, %)042.89 ± 1.23aA44.56 ± 1.12aA45.78 ± 1.34aA43.45 ± 1.23aA44.12 ± 1.34aA46.34 ± 1.01aA47.89 ± 1.23aA46.78 ± 1.12aA47.01 ± 1.34aA2432.45 ± 1.45bB34.78 ± 1.23bB36.12 ± 1.45bB33.89 ± 1.34bB35.23 ± 1.45bB44.56 ± 0.98bA45.78 ± 1.12bA43.90 ± 1.01bA44.12 ± 1.23bA4827.89 ± 1.67cC30.45 ± 1.45cC32.67 ± 1.56cC29.78 ± 1.56cC31.12 ± 1.67cC40.89 ± 1.10cA42.34 ± 1.34cA39.56 ± 1.23cA41.01 ± 1.45cA7215.34 ± 1.89dC18.12 ± 1.67dC20.45 ± 1.78dC17.89 ± 1.89dC19.23 ± 1.78dC29.67 ± 1.23dA31.23 ± 1.45dA28.12 ± 1.34dA30.01 ± 1.56dAA Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) Motility parameters of chilled canine semen stored for up to 72 h after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD) A Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) The data in Table 2 indicate that all kinematic parameters of canine spermatozoa—curvilinear velocity (VCL), straight-line velocity (VSL), average path velocity (VAP), linearity (LIN), straightness (STR), amplitude of lateral head displacement (ALH), and beat-cross frequency (BCF)—declined significantly (p < 0.05) with increasing storage time up to 72 h, reflecting the progressive deterioration of sperm motility characteristics during cold preservation. However, semen samples supplemented with combined apigenin and N-acetylcysteine amide (NACA) maintained significantly higher values for all motility and kinematic parameters compared with the control and single-antioxidant groups at each storage interval. Among the tested combinations, 0.4 mM apigenin + 1 mM NACA consistently yielded the highest VCL, VSL, and VAP values, indicating superior maintenance of sperm velocity and trajectory during prolonged storage. The LIN and STR parameters also improved notably in the combined treatment groups after 72 h, suggesting better progressive and directed motility. Similarly, higher ALH and BCF values in the combination groups reflected enhanced flagellar activity and beat pattern stability, which are indicative of preserved mitochondrial function and membrane fluidity. Collectively, these results demonstrate that the synergistic application of apigenin and NACA effectively protects sperm kinematics during 72 h of storage by mitigating oxidative stress and sustaining energy-dependent motility mechanisms. Table 2Motility and kinematic characteristics of extended for 72 h canine semen after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD)AnalysisStorage (h)ControlA-0.2 mMA-0.4 mMNACA-0.5 mMNACA-1 mMA-0.2 mM + NACA-0.5 mMA-0.4 mM + NACA-1 mMA-0.2 mM + NACA-1 mMA-0.4 mM + NACA-0.5 mMCurvilinear Velocity (VCL, µm/s)084.56 ± 1.45aA86.78 ± 1.23aA87.89 ± 1.34aA85.34 ± 1.45aA86.12 ± 1.34aA88.45 ± 1.12aA89.67 ± 1.23aA88.01 ± 1.34aA88.78 ± 1.45aA2469.23 ± 1.67bB71.45 ± 1.34bB73.67 ± 1.45bB70.78 ± 1.56bB72.34 ± 1.45bB86.12 ± 1.23bA87.34 ± 1.34bA85.56 ± 1.23bA86.45 ± 1.45bA4861.89 ± 1.89cC65.12 ± 1.56cC67.34 ± 1.67cC63.45 ± 1.67cC65.78 ± 1.56cC80.56 ± 1.34cA82.78 ± 1.45cA79.89 ± 1.34cA81.23 ± 1.56cA7250.34 ± 2.01dC54.78 ± 1.78dC56.90 ± 1.89dC53.12 ± 1.89dC55.45 ± 1.78dC67.89 ± 1.45dA69.12 ± 1.67dA66.34 ± 1.56dA68.01 ± 1.78dAStraight-Line Velocity (VSL, µm/s)043.78 ± 1.12aA45.23 ± 0.98aA46.45 ± 1.12aA44.56 ± 1.01aA45.12 ± 1.12aA47.01 ± 0.89aA48.34 ± 1.01aA46.89 ± 0.98aA47.56 ± 1.12aA2436.89 ± 1.34bB38.45 ± 1.12bB40.12 ± 1.23bB37.78 ± 1.23bB39.23 ± 1.12bB45.12 ± 0.87bA46.45 ± 0.98bA44.56 ± 0.89bA45.34 ± 1.01bA4832.45 ± 1.56cC34.78 ± 1.34cC36.89 ± 1.45cC33.89 ± 1.34cC35.45 ± 1.45cC41.56 ± 0.95cA42.78 ± 1.12cA40.89 ± 1.01cA41.23 ± 1.23cA7226.12 ± 1.78dC29.45 ± 1.56dC31.67 ± 1.67dC28.34 ± 1.67dC30.12 ± 1.56dC37.89 ± 1.03dA39.12 ± 1.23dA36.78 ± 1.12dA38.01 ± 1.34dAAverage Path Velocity (VAP, µm/s)063.89 ± 1.23aA65.34 ± 1.12aA66.56 ± 1.23aA64.78 ± 1.12aA65.45 ± 1.23aA67.89 ± 1.01aA69.12 ± 1.12aA68.34 ± 1.01aA68.78 ± 1.23aA2453.45 ± 1.45bB55.78 ± 1.23bB57.12 ± 1.34bB54.89 ± 1.34bB56.23 ± 1.23bB65.34 ± 0.98bA66.67 ± 1.01bA64.56 ± 0.89bA65.45 ± 1.12bA4846.78 ± 1.67cC49.12 ± 1.45cC51.34 ± 1.56cC48.45 ± 1.56cC50.12 ± 1.45cC61.56 ± 1.10cA63.78 ± 1.23cA60.89 ± 1.12cA62.01 ± 1.34cA7238.12 ± 1.89dC41.45 ± 1.67dC43.67 ± 1.78dC40.78 ± 1.78dC42.34 ± 1.67dC58.90 ± 1.12dA60.12 ± 1.34dA57.23 ± 1.23dA59.45 ± 1.45dALinearity (LIN, %)050.34 ± 1.01dB52.12 ± 0.89dA52.56 ± 1.01dA51.45 ± 0.98dA51.89 ± 1.01dA53.01 ± 0.87dA53.45 ± 0.98dA52.78 ± 0.89dA53.12 ± 1.01dA2451.45 ± 1.23cB50.78 ± 1.01cB51.01 ± 1.12cB50.34 ± 1.12cB50.67 ± 1.01cB51.23 ± 0.95cB51.67 ± 1.01cB50.89 ± 0.87cB51.12 ± 1.12cB4852.67 ± 1.45bB51.34 ± 1.23bB51.78 ± 1.34bB50.89 ± 1.23bB51.12 ± 1.34bB50.56 ± 1.10bB50.89 ± 1.23bB50.12 ± 1.01bB50.45 ± 1.34bB7263.78 ± 1.67aA68.45 ± 1.34aA67.89 ± 1.56aA66.12 ± 1.45aA67.23 ± 1.56aA69.12 ± 1.12aA70.34 ± 1.23aA68.78 ± 1.01aA69.56 ± 1.34aAStraightness (STR, %)076.45 ± 1.12aB78.12 ± 1.01aA78.56 ± 1.12aA77.34 ± 1.01aA77.89 ± 1.12aA79.01 ± 0.89aA79.45 ± 1.01aA78.78 ± 0.98aA79.12 ± 1.12aA2475.89 ± 1.34bB77.45 ± 0.98bA77.89 ± 1.01bA76.67 ± 0.98bA77.12 ± 1.01bA78.34 ± 0.87bA78.78 ± 0.98bA77.89 ± 0.89bA78.23 ± 1.01bA4874.23 ± 1.56cB76.78 ± 1.12cA77.12 ± 1.23cA75.89 ± 1.12cA76.34 ± 1.23cA77.56 ± 0.95cA77.89 ± 1.01cA76.90 ± 0.87cA77.34 ± 1.12cA7273.12 ± 1.78dB75.45 ± 1.34dA75.89 ± 1.45dA74.56 ± 1.34dA75.12 ± 1.45dA76.23 ± 1.01dA76.67 ± 1.12dA75.78 ± 0.98dA76.01 ± 1.23dAAmplitude of Lateral Head Displacement (ALH, µm)04.34 ± 0.21aB4.67 ± 0.18aA4.78 ± 0.20aA4.45 ± 0.19aA4.56 ± 0.21aA4.89 ± 0.17aA5.01 ± 0.19aA4.90 ± 0.18aA4.95 ± 0.20aA244.01 ± 0.32bB4.34 ± 0.23bA4.45 ± 0.25bA4.12 ± 0.24bA4.23 ± 0.25bA4.67 ± 0.20bA4.78 ± 0.22bA4.56 ± 0.19bA4.70 ± 0.23bA483.67 ± 0.45cC3.89 ± 0.25cA4.01 ± 0.28cA3.78 ± 0.26cA3.89 ± 0.28cA4.23 ± 0.23cA4.34 ± 0.25cA4.12 ± 0.21cA4.28 ± 0.26cA723.23 ± 0.56dC3.56 ± 0.28dA3.67 ± 0.31dA3.45 ± 0.29dA3.56 ± 0.31dA3.89 ± 0.25dA4.01 ± 0.27dA3.78 ± 0.23dA3.95 ± 0.28dABeat-Cross Frequency (BCF, Hz)06.56 ± 0.23aB6.89 ± 0.19aA7.01 ± 0.21aA6.78 ± 0.20aA6.90 ± 0.21aA7.12 ± 0.18aA7.23 ± 0.20aA7.10 ± 0.19aA7.15 ± 0.21aA246.23 ± 0.34bB6.56 ± 0.21bA6.67 ± 0.23bA6.45 ± 0.22bA6.56 ± 0.23bA6.89 ± 0.20bA7.01 ± 0.22bA6.78 ± 0.18bA6.90 ± 0.23bA485.89 ± 0.45cC6.23 ± 0.23cA6.34 ± 0.25cA6.12 ± 0.24cA6.23 ± 0.25cA6.56 ± 0.21cA6.67 ± 0.23cA6.45 ± 0.20cA6.58 ± 0.25cA725.56 ± 0.56dC5.89 ± 0.25dA6.01 ± 0.28dA5.78 ± 0.26dA5.89 ± 0.28dA6.23 ± 0.23dA6.34 ± 0.25dA6.12 ± 0.21dA6.25 ± 0.27dAA Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) Motility and kinematic characteristics of extended for 72 h canine semen after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD) A Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) The results in Table 3 show that sperm plasma membrane functionality, viability, and DNA integrity of canine semen decreased significantly (p < 0.05) with increasing storage duration up to 72 h across all treatment groups, indicating the detrimental effects of prolonged cold storage on sperm structural and functional stability. Nevertheless, supplementation of the semen extender with combined apigenin and N-acetylcysteine amide (NACA) markedly preserved these parameters compared with the control and individual antioxidant groups at every storage interval. Specifically, the combination of 0.4 mM apigenin with 1 mM NACA consistently yielded the highest values of plasma membrane integrity, viability, and DNA stability, maintaining approximately 15–20% higher levels than the control after 72 h. These results suggest that the synergistic antioxidant action of apigenin and NACA effectively protects spermatozoa from oxidative damage, lipid peroxidation, and DNA fragmentation during extended storage. The preservation of membrane functionality and DNA integrity further implies that this combination supports mitochondrial activity and prevents apoptotic or necrotic alterations in sperm cells, thereby improving the overall post-storage fertility potential of canine semen. Table 3Sperm integrity and viability parameters of extended for 72 h canine semen after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD)AnalysisStorage (h)ControlA-0.2 mMA-0.4 mMNACA-0.5 mMNACA-1 mMA-0.2 mM + NACA-0.5 mMA-0.4 mM + NACA-1 mMA-0.2 mM + NACA-1 mMA-0.4 mM + NACA-0.5 mMSperm Plasma Membrane Functionality (%)087.89 ± 1.23aA89.34 ± 1.12aA90.56 ± 1.23aA88.45 ± 1.12aA89.12 ± 1.23aA91.23 ± 1.01aA92.45 ± 1.12aA90.78 ± 1.01aA91.56 ± 1.23aA2477.45 ± 1.45bB79.12 ± 1.23bB81.34 ± 1.34bB78.67 ± 1.34bB80.23 ± 1.23bB86.45 ± 0.98bA87.67 ± 1.01bA85.89 ± 0.87bA86.12 ± 1.12bA4860.12 ± 1.67cC63.89 ± 1.45cC66.12 ± 1.56cC62.34 ± 1.56cC64.78 ± 1.45cC74.56 ± 1.10cA76.23 ± 1.23cA73.45 ± 1.12cA75.01 ± 1.34cA7242.34 ± 1.89dC46.78 ± 1.67dC49.01 ± 1.78dC45.12 ± 1.78dC47.45 ± 1.67dC62.89 ± 1.12dA64.12 ± 1.34dA61.23 ± 1.23dA63.45 ± 1.45dAViability (%)093.45 ± 1.01aA95.12 ± 0.89aA96.34 ± 1.01aA94.23 ± 0.98aA95.01 ± 1.01aA96.78 ± 0.87aA97.89 ± 0.98aA96.45 ± 0.89aA97.12 ± 1.01aA2483.78 ± 1.23bB85.67 ± 1.12bB87.89 ± 1.23bB84.56 ± 1.23bB86.12 ± 1.12bB93.45 ± 0.95bA94.67 ± 1.01bA92.78 ± 0.87bA93.01 ± 1.12bA4866.12 ± 1.45cC69.45 ± 1.34cC72.34 ± 1.56cC68.78 ± 1.45cC70.23 ± 1.56cC80.89 ± 1.10cA82.12 ± 1.23cA79.56 ± 1.12cA81.34 ± 1.34cA7248.34 ± 1.67dC52.78 ± 1.56dC55.67 ± 1.78dC51.45 ± 1.78dC53.89 ± 1.67dC69.23 ± 1.12dA71.01 ± 1.34dA68.12 ± 1.23dA70.45 ± 1.45dADNA Integrity (%)090.12 ± 0.98aA91.45 ± 0.87aA92.67 ± 1.01aA90.89 ± 0.95aA91.56 ± 1.01aA93.01 ± 0.84aA94.23 ± 0.95aA92.78 ± 0.87aA93.45 ± 1.01aA2483.45 ± 1.12bB85.23 ± 0.98bB87.12 ± 1.12bB84.78 ± 1.01bB86.34 ± 1.12bB90.45 ± 0.90bA91.67 ± 1.01bA89.89 ± 0.87bA90.12 ± 1.12bA4876.78 ± 1.34cC79.56 ± 1.23cC82.34 ± 1.45cC78.45 ± 1.34cC80.12 ± 1.45cC87.67 ± 1.05cA89.01 ± 1.12cA86.78 ± 1.01cA88.23 ± 1.23cA7263.89 ± 1.56dC67.45 ± 1.45dC70.12 ± 1.67dC66.12 ± 1.67dC68.78 ± 1.56dC81.23 ± 1.10dA83.45 ± 1.23dA80.56 ± 1.12dA82.01 ± 1.34dAA Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) Sperm integrity and viability parameters of extended for 72 h canine semen after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD) A Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) The findings presented in Table 4 demonstrate that storage time exerted a significant negative effect (p < 0.05) on the antioxidant status of canine semen, as reflected by progressive declines in total antioxidant capacity (TAC), glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase (CAT) activities, reduced glutathione (GSH) content, and total thiol groups (TSH) over 72 h of storage. Concurrently, oxidative stress biomarkers, including malondialdehyde (MDA), hydrogen peroxide (H₂O₂) content, and protein carbonyl levels, increased markedly in the control group with extended storage time, confirming enhanced lipid peroxidation and protein oxidation due to reactive oxygen species (ROS) accumulation. However, supplementation with apigenin and N-acetylcysteine amide (NACA), either individually or in combination, significantly ameliorated these oxidative alterations. The combined treatments, particularly 0.4 mM apigenin + 1 mM NACA, consistently exhibited the highest antioxidant enzyme activities and lowest oxidative damage indicators at all time points, indicating a synergistic enhancement of redox balance within the semen extender. These results clearly suggest that the co-administration of apigenin and NACA provides superior protection against oxidative stress compared with their individual use. This synergistic antioxidant effect likely results from the combined free radical scavenging ability of apigenin and the thiol-based redox-restoring function of NACA, which together reinforce the enzymatic and non-enzymatic antioxidant defense systems of spermatozoa. Consequently, the maintenance of higher TAC, GSH, and thiol group levels, along with reduced MDA, H₂O₂, and protein carbonyl contents, indicates that this combination effectively prevents lipid peroxidation and protein oxidation, thereby preserving membrane integrity and cellular functionality during extended storage. Overall, these findings confirm the pivotal role of apigenin–NACA combinations in enhancing the oxidative stability and longevity of cryopreserved or chilled canine semen. Table 4Antioxidant and oxidative stress parameters of extended for 72 h canine semen after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD)AnalysisStorage (h)ControlA-0.2 mMA-0.4 mMNACA-0.5 mMNACA-1 mMA-0.2 mM + NACA-0.5 mMA-0.4 mM + NACA-1 mMA-0.2 mM + NACA-1 mMA-0.4 mM + NACA-0.5 mMTotal Antioxidant Capacity (TAC, mmol/L)01.45 ± 0.11aC1.62 ± 0.09aB1.70 ± 0.10aB1.58 ± 0.12aB1.65 ± 0.11aB1.78 ± 0.10aA1.89 ± 0.12aA1.82 ± 0.09aA1.85 ± 0.11aA241.01 ± 0.14bC1.48 ± 0.08bB1.56 ± 0.09bB1.44 ± 0.11bB1.52 ± 0.10bB1.67 ± 0.09bA1.78 ± 0.11bA1.70 ± 0.08bA1.73 ± 0.10bA480.67 ± 0.16cC1.34 ± 0.10cB1.42 ± 0.11cB1.30 ± 0.13cB1.38 ± 0.12cB1.54 ± 0.11cA1.65 ± 0.13cA1.58 ± 0.10cA1.61 ± 0.12cA720.35 ± 0.18dC1.20 ± 0.12dB1.28 ± 0.13dB1.16 ± 0.15dB1.24 ± 0.14dB1.40 ± 0.13dA1.52 ± 0.15dA1.44 ± 0.11dA1.47 ± 0.13dAGlutathione Peroxidase (GPx, U/mL)010.89 ± 0.34aC12.34 ± 0.28aB12.78 ± 0.31aB11.45 ± 0.36aB12.01 ± 0.34aB13.23 ± 0.25aA13.89 ± 0.28aA13.45 ± 0.26aA13.67 ± 0.30aA249.23 ± 0.45bC11.56 ± 0.23bB12.01 ± 0.25bB10.78 ± 0.28bB11.34 ± 0.26bB12.45 ± 0.20bA13.12 ± 0.23bA12.78 ± 0.19bA12.90 ± 0.25bA487.89 ± 0.56cC10.78 ± 0.25cB11.23 ± 0.28cB9.90 ± 0.31cB10.56 ± 0.28cB11.67 ± 0.23cA12.34 ± 0.25cA12.01 ± 0.21cA12.23 ± 0.28cA726.45 ± 0.67dC9.90 ± 0.28dB10.45 ± 0.31dB9.12 ± 0.34dB9.78 ± 0.31dB10.89 ± 0.25dA11.56 ± 0.27dA11.23 ± 0.23dA11.45 ± 0.30dASuperoxide Dismutase (SOD, U/mL)07.45 ± 0.23aC8.78 ± 0.19aB9.12 ± 0.21aB8.01 ± 0.25aB8.45 ± 0.23aB9.34 ± 0.18aA9.78 ± 0.20aA9.23 ± 0.17aA9.56 ± 0.22aA246.23 ± 0.34bC8.01 ± 0.17bB8.45 ± 0.19bB7.56 ± 0.20bB7.89 ± 0.19bB8.67 ± 0.15bA9.12 ± 0.18bA8.90 ± 0.16bA9.01 ± 0.20bA485.12 ± 0.45cC7.34 ± 0.20cB7.78 ± 0.23cB6.89 ± 0.22cB7.23 ± 0.21cB7.89 ± 0.17cA8.34 ± 0.20cA8.12 ± 0.18cA8.23 ± 0.23cA724.34 ± 0.56dC6.56 ± 0.23dB6.90 ± 0.25dB6.12 ± 0.24dB6.45 ± 0.23dB7.12 ± 0.19dA7.56 ± 0.21dA7.34 ± 0.17dA7.45 ± 0.20dAMalondialdehyde (MDA, nmol/mL)02.45 ± 0.20dA2.12 ± 0.17dB2.00 ± 0.19dB2.23 ± 0.18dB2.10 ± 0.20dB1.89 ± 0.15dC1.78 ± 0.16dC1.95 ± 0.14dC1.82 ± 0.17dC243.12 ± 0.23cA2.34 ± 0.19cB2.23 ± 0.21cB2.56 ± 0.20cB2.45 ± 0.22cB2.01 ± 0.17cC1.90 ± 0.18cC2.12 ± 0.15cC1.98 ± 0.19cC484.56 ± 0.25bA2.78 ± 0.21bB2.67 ± 0.23bB3.01 ± 0.22bB2.89 ± 0.24bB2.34 ± 0.19bC2.23 ± 0.20bC2.45 ± 0.17bC2.30 ± 0.21bC726.78 ± 0.28aA3.45 ± 0.23aB3.34 ± 0.25aB3.67 ± 0.24aB3.56 ± 0.26aB2.89 ± 0.20aC2.78 ± 0.21aC2.90 ± 0.18aC2.67 ± 0.23aCCatalase Activity (CAT, U/mL)014.56 ± 0.56aC16.23 ± 0.45aB16.78 ± 0.50aB15.34 ± 0.58aB15.89 ± 0.56aB17.45 ± 0.40aA18.12 ± 0.45aA17.67 ± 0.38aA17.90 ± 0.50aA2412.34 ± 0.67bC15.45 ± 0.38bB15.90 ± 0.45bB14.56 ± 0.45bB15.12 ± 0.45bB16.78 ± 0.35bA17.34 ± 0.40bA16.90 ± 0.33bA17.12 ± 0.45bA4810.12 ± 0.78cC14.67 ± 0.41cB15.12 ± 0.50cB13.78 ± 0.50cB14.34 ± 0.50cB15.90 ± 0.38cA16.56 ± 0.45cA16.12 ± 0.36cA16.34 ± 0.50cA728.45 ± 0.89dC13.89 ± 0.45dB14.34 ± 0.56dB12.90 ± 0.56dB13.56 ± 0.56dB15.12 ± 0.42dA15.78 ± 0.50dA14.89 ± 0.40dA15.23 ± 0.45dAH₂O₂ Content(nMol/40 × 10⁶ sperm)05.60 ± 0.28dA4.75 ± 0.24dB4.55 ± 0.25dB5.11 ± 0.26dB4.96 ± 0.26dB4.27 ± 0.22dC4.06 ± 0.23dC4.34 ± 0.21dC4.20 ± 0.24dC246.44 ± 0.31cA5.25 ± 0.25cB5.04 ± 0.28cB5.95 ± 0.30cB5.74 ± 0.29cB4.76 ± 0.24cC4.55 ± 0.25cC4.83 ± 0.22cC4.69 ± 0.26cC487.28 ± 0.35bA6.16 ± 0.28bB5.95 ± 0.31bB6.78 ± 0.33bB6.51 ± 0.32bB5.60 ± 0.25bC5.39 ± 0.26bC5.67 ± 0.24bC5.53 ± 0.28bC728.47 ± 0.38aA7.07 ± 0.31aB6.85 ± 0.35aB7.77 ± 0.36aB7.49 ± 0.35aB6.37 ± 0.28aC6.15 ± 0.30aC6.51 ± 0.26aC6.30 ± 0.31aCReduced Glutathione Levels (GSH, µM)015.67 ± 0.78aC17.89 ± 0.65aB18.34 ± 0.70aB16.45 ± 0.80aB17.12 ± 0.78aB19.56 ± 0.60aA20.23 ± 0.65aA19.78 ± 0.58aA20.01 ± 0.70aA2413.45 ± 0.89bC16.78 ± 0.58bB17.23 ± 0.65bB15.23 ± 0.70bB15.89 ± 0.67bB18.45 ± 0.55bA19.12 ± 0.60bA18.67 ± 0.52bA18.90 ± 0.65bA4811.23 ± 1.00cC15.67 ± 0.61cB16.12 ± 0.70cB14.12 ± 0.75cB14.78 ± 0.70cB17.34 ± 0.58cA18.01 ± 0.65cA17.56 ± 0.55cA17.78 ± 0.70cA729.45 ± 1.12dC14.56 ± 0.65dB15.01 ± 0.75dB13.01 ± 0.80dB13.67 ± 0.75dB16.23 ± 0.60dA16.90 ± 0.70dA16.45 ± 0.58dA16.67 ± 0.65dAProtein Carbonyl Content (nmol/mg protein)01.23 ± 0.10dA1.01 ± 0.08dB0.95 ± 0.09dB1.12 ± 0.10dB1.05 ± 0.09dB0.89 ± 0.07dC0.78 ± 0.08dC0.85 ± 0.06dC0.80 ± 0.07dC241.56 ± 0.12cA1.23 ± 0.09cB1.15 ± 0.10cB1.34 ± 0.11cB1.28 ± 0.10cB1.01 ± 0.08cC0.90 ± 0.09cC0.98 ± 0.07cC0.93 ± 0.08cC482.01 ± 0.14bA1.45 ± 0.10bB1.38 ± 0.12bB1.67 ± 0.13bB1.56 ± 0.12bB1.23 ± 0.09bC1.12 ± 0.10bC1.20 ± 0.08bC1.15 ± 0.09bC722.89 ± 0.16aA1.78 ± 0.12aB1.70 ± 0.14aB2.01 ± 0.15aB1.89 ± 0.14aB1.45 ± 0.10aC1.34 ± 0.11aC1.45 ± 0.09aC1.38 ± 0.12aCTotal Thiol Groups (TSH, µM/mg protein)025.34 ± 1.23aC27.89 ± 1.01aB28.45 ± 1.10aA26.12 ± 1.20aB26.78 ± 1.15aB29.67 ± 0.95aA30.34 ± 1.05aA29.90 ± 0.90aA30.12 ± 1.10aA2422.56 ± 1.34bC26.78 ± 0.95bB27.34 ± 1.05bA24.90 ± 1.10bB25.56 ± 1.05bB28.45 ± 0.90bA29.12 ± 0.95bA28.67 ± 0.85bA28.90 ± 1.05bA4819.78 ± 1.45cC25.67 ± 0.98cB26.12 ± 1.15cA23.78 ± 1.15cB24.45 ± 1.10cB27.34 ± 0.85cA28.01 ± 0.90cA27.56 ± 0.80cA27.78 ± 1.00cA7216.90 ± 1.56dC24.56 ± 1.05dB25.01 ± 1.20dA22.67 ± 1.20dB23.34 ± 1.15dB26.23 ± 0.80dA26.90 ± 0.95dA26.45 ± 0.75dA26.67 ± 0.90dAA Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) Antioxidant and oxidative stress parameters of extended for 72 h canine semen after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD) H₂O₂ Content (nMol/40 × 10⁶ sperm) A Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) The data in Table 5 indicate that prolonged storage significantly (p < 0.05) reduced intracellular ATP levels, oxygen consumption rate (OCR), and the proportion of sperm with high mitochondrial membrane potential (MMP) in all treatment groups, reflecting a progressive decline in mitochondrial function and energy metabolism over 72 h. Supplementation of the semen extender with apigenin and N-acetylcysteine amide (NACA), particularly in combination, markedly preserved mitochondrial function, as evidenced by higher ATP concentrations, enhanced OCR, and greater percentages of sperm exhibiting high MMP compared with control or individual antioxidant treatments at each time point. Notably, the combination of 0.4 mM apigenin and 1 mM NACA consistently showed the highest mitochondrial activity and energy status, maintaining ATP levels and MMP approximately 40–50% higher than the control after 72 h. These findings suggest that co-administration of apigenin and NACA effectively supports mitochondrial integrity, sustains oxidative phosphorylation, and mitigates energy depletion in chilled canine sperm, thereby potentially enhancing post-storage motility and overall fertility potential. Table 5Mitochondrial and energy metabolism parameters of chilled canine semen stored for up to 72 h after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD)AnalysisStorage (h)ControlA-0.2 mMA-0.4 mMNACA-0.5 mMNACA-1 mMA-0.2 mM + NACA-0.5 mMA-0.4 mM + NACA-1 mMA-0.2 mM + NACA-1 mMA-0.4 mM + NACA-0.5 mMIntracellular ATP Levels (nmol/108 cells)00.119 ± 0.008aC0.123 ± 0.007aB0.128 ± 0.009aB0.120 ± 0.007aB0.124 ± 0.008aB0.137 ± 0.006aA0.141 ± 0.007aA0.139 ± 0.006aA0.140 ± 0.007aA240.095 ± 0.010bC0.101 ± 0.006bB0.106 ± 0.009bB0.099 ± 0.007bB0.102 ± 0.008bB0.115 ± 0.006bA0.119 ± 0.006bA0.117 ± 0.005bA0.118 ± 0.007bA480.071 ± 0.012cC0.085 ± 0.007cB0.089 ± 0.010cB0.081 ± 0.007cB0.086 ± 0.008cB0.098 ± 0.005cA0.101 ± 0.006cA0.099 ± 0.005cA0.100 ± 0.006cA720.050 ± 0.013dC0.079 ± 0.008dB0.082 ± 0.010dB0.075 ± 0.007dB0.079 ± 0.009dB0.091 ± 0.005dA0.096 ± 0.005dA0.093 ± 0.004dA0.095 ± 0.006dAOxygen Consumption Rate(OCR, pmol/min/106 cells)00.75 ± 0.05aC0.80 ± 0.04aB0.85 ± 0.06aB0.78 ± 0.03aB0.82 ± 0.05aB0.90 ± 0.03aA0.95 ± 0.04aA0.92 ± 0.02aA0.93 ± 0.05aA240.60 ± 0.07bC0.70 ± 0.05bB0.75 ± 0.06bB0.68 ± 0.04bB0.72 ± 0.06bB0.85 ± 0.03bA0.90 ± 0.04bA0.87 ± 0.02bA0.88 ± 0.05bA480.45 ± 0.09cC0.65 ± 0.06cB0.70 ± 0.07cB0.63 ± 0.05cB0.67 ± 0.07cB0.80 ± 0.04cA0.85 ± 0.05cA0.82 ± 0.03cA0.83 ± 0.06cA720.30 ± 0.11dC0.60 ± 0.07dB0.65 ± 0.08dB0.58 ± 0.06dB0.62 ± 0.08dB0.75 ± 0.05dA0.80 ± 0.06dA0.77 ± 0.04dA0.78 ± 0.07dAMitochondrial Membrane Potential (MMP, % high potential)085.12 ± 1.23aC86.45 ± 1.15aB87.78 ± 1.28aB86.12 ± 1.34aB86.89 ± 1.47aB88.90 ± 1.01aA89.56 ± 1.12aA89.23 ± 0.98aA89.34 ± 1.23aA2478.56 ± 1.45bC80.12 ± 1.09bB81.34 ± 1.23bB79.67 ± 1.47bB80.45 ± 1.56bB83.78 ± 0.95bA84.56 ± 1.01bA84.12 ± 0.87bA84.23 ± 1.12bA4871.23 ± 1.67cC74.56 ± 1.21cB75.89 ± 1.35cB73.45 ± 1.56cB74.78 ± 1.67cB78.90 ± 1.10cA79.67 ± 1.23cA79.23 ± 1.12cA79.34 ± 1.34cA7265.89 ± 1.89dC68.90 ± 1.14dB70.12 ± 1.45dB67.89 ± 1.78dB69.23 ± 1.89dB73.45 ± 1.12dA74.12 ± 1.34dA73.78 ± 1.23dA73.90 ± 1.45dAA Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) Mitochondrial and energy metabolism parameters of chilled canine semen stored for up to 72 h after addition of different combinations of apigenin and N-acetylcysteine amide in semen extender (Mean ± SD) Oxygen Consumption Rate (OCR, pmol/min/106 cells) A Apigenin, NACA N-Acetylcysteine Amide. Different lowercase superscripts (a-e) within the same column indicate a significant effect of storage time within each treatment (p < 0.05). Different uppercase superscripts (A-C) within the same row indicate a significant effect of treatment within each storage time (p < 0.05) Discussion The present study evaluated the protective effects of apigenin and N-acetylcysteine amide (NACA), individually and in combination, on the quality, antioxidant status, and mitochondrial function of canine spermatozoa during liquid storage at 5 °C. The findings demonstrated that both antioxidants significantly ameliorated the deleterious effects of cold storage, with the combined supplementation of 0.4 mM apigenin and 1 mM NACA showing superior protective efficacy across all evaluated parameters. Sperm motility and kinematic parameters Chilled storage is known to induce a progressive decline in sperm motility due to oxidative damage, loss of membrane fluidity, and reduced mitochondrial activity [12, 22]. In the present study, total and progressive motility, as well as CASA-derived kinematic parameters (VCL, VSL, VAP, LIN, STR, ALH, and BCF), declined significantly during 72 h of storage in all groups; however, the apigenin + NACA combination maintained substantially higher motility and velocity parameters. These results indicate a synergistic interaction between apigenin’s radical scavenging ability and NACA’s thiol-based antioxidant capacity, which together protect membrane integrity and energy metabolism. Consistent with these findings [12], reported that supplementation of canine semen extenders with N-acetylcysteine significantly improved motility and reduced reactive oxygen species (ROS) generation during chilled storage. Similarly [17] and [20], found that apigenin enhanced post-thaw motility and mitochondrial activity in rooster and human spermatozoa, respectively. The synergistic enhancement observed in the current study parallels the improved motility reported for combined antioxidants such as apigenin + ferulic acid in boar sperm [26], suggesting that co-administration of different antioxidant classes can offer broader protection against diverse ROS species. Plasma membrane integrity, viability, and DNA stability Sperm plasma membranes, rich in polyunsaturated fatty acids, are highly vulnerable to lipid peroxidation, leading to loss of viability and membrane functionality [2]. In the present work, apigenin and NACA supplementation—particularly in combination—preserved plasma membrane integrity, viability, and DNA stability during 72 h of storage. The improved HOST response and reduced DNA fragmentation observed in the apigenin + NACA group imply effective protection against ROS-induced lipid and chromatin oxidation. These results corroborate the findings of [10], who reported that procyanidin supplementation preserved membrane integrity and viability of chilled canine sperm by suppressing oxidative stress. Similarly [22], demonstrated that inclusion of catalase in Tris-based extenders enhanced sperm viability by neutralizing hydrogen peroxide. The current study expands on these observations by showing that combining apigenin, a flavonoid with mitochondrial-protective effects (Najafi et al., 2024), and NACA, a glutathione precursor [11], provides dual protection at both the membrane and genomic levels. Antioxidant status and oxidative stress markers Cold storage disrupts redox homeostasis in spermatozoa, decreasing enzymatic antioxidant activities and increasing oxidative biomarkers such as MDA, H₂O₂, and protein carbonyls [25, 27]. In the present study, total antioxidant capacity (TAC), GPx, SOD, CAT activities, and non-enzymatic antioxidants (GSH and TSH) were significantly higher in the antioxidant-supplemented groups, particularly in apigenin + NACA, compared with the control. Conversely, MDA, H₂O₂, and protein carbonyl levels were markedly reduced. These outcomes are consistent with the results of [12], who showed that NAC supplementation mitigated ROS accumulation and preserved antioxidant enzyme activity in chilled canine semen. Similar trends were observed by [15] in goat spermatozoa, where NAC supplementation increased SOD and CAT activity while reducing lipid peroxidation. The improved redox balance found in the current study can be attributed to the complementary mechanisms of the two antioxidants: apigenin directly scavenges free radicals and stabilizes mitochondrial function, while NACA replenishes intracellular GSH and enhances thiol-based redox cycling. The significant elevation in TAC and thiol content supports this synergistic interaction. Mitochondrial function and energy metabolism Mitochondria play a critical role in sperm motility through ATP generation via oxidative phosphorylation. However, these organelles are also the primary sites of ROS production during chilling [28]. The marked decline in ATP levels, oxygen consumption rate (OCR), and mitochondrial membrane potential (MMP) observed in the control group indicates mitochondrial dysfunction under oxidative stress. Conversely, semen supplemented with apigenin and NACA—especially the combination—showed preserved mitochondrial integrity and significantly higher ATP production. These findings align with previous reports showing that antioxidants improve mitochondrial performance in sperm cells [17]. demonstrated that apigenin maintained mitochondrial potential and ATP content in rooster sperm, while [14] and [15] found that NAC enhanced mitochondrial enzyme activity and testicular blood flow, respectively, under oxidative stress conditions. The results of the present study indicate that apigenin and NACA act cooperatively to prevent mitochondrial depolarization and sustain oxidative phosphorylation, thereby supporting energy-dependent motility and viability during prolonged storage. This cooperative effect likely arises from apigenin’s ability to directly protect mitochondrial membranes and electron transport chain components from ROS attack, combined with NACA’s capacity to boost GSH-dependent detoxification and regenerate other antioxidants within the mitochondrial matrix. Comparative evaluation and mechanistic insights When compared to other antioxidants tested in canine semen—such as curcumin [27], catalase [22], procyanidin [10], and Tribulus terrestris extract [25]—the combination of apigenin and NACA exhibited a broader and more potent protective profile. Unlike single antioxidants that target specific ROS pathways, this combination provides both direct free radical scavenging (via apigenin) and reinforcement of endogenous antioxidant systems (via NACA). Such multi-level protection not only mitigates lipid peroxidation and protein oxidation but also stabilizes mitochondrial energetics, ensuring sustained motility and structural integrity throughout storage. The superior performance of the apigenin + NACA group highlights a plausible mechanistic model: apigenin primarily acts as a mitochondrially-targeted radical scavenger preserving membrane and MMP integrity, while NACA reinforces the glutathione-dependent antioxidant defense system, collectively preventing escalation of oxidative cascades more effectively than individual treatments. Limitations Although the present study provides clear evidence of the synergistic protective effects of apigenin and N-acetylcysteine amide on chilled canine spermatozoa, several limitations should be acknowledged. The experiments were performed using pooled ejaculates from only five mixed-breed dogs, which, while helpful in reducing individual variation, may not fully reflect the variability encountered in different breeds, ages, or dogs with suboptimal initial semen quality. Breed-specific differences in sperm membrane composition and baseline antioxidant capacity, as well as potential age-related variations in susceptibility to oxidative stress, could influence the generalizability of these findings. Furthermore, the study was restricted to in vitro parameters and 72-hour chilled storage; no in vivo fertility trials (e.g., intrauterine insemination) were conducted to confirm whether the observed improvements in motility, mitochondrial function, and DNA integrity translate into higher pregnancy rates or litter sizes. The optimal concentrations identified here (0.4 mM apigenin + 1 mM NACA) were selected based on preliminary dose–response tests, but broader concentration ranges or alternative combinations might yield even better outcomes. Finally, the cost-effectiveness and long-term stability of these antioxidants in commercial extenders and their potential regulatory approval for routine breeding use remain to be evaluated. Future studies addressing these points would strengthen the practical applicability of this antioxidant combination in canine reproductive programs. Conclusion In summary, the synergistic combination of apigenin and N-acetylcysteine amide significantly enhances the preservation of canine sperm during liquid storage by maintaining motility, membrane integrity, DNA stability, antioxidant defense, and mitochondrial activity. Therefore, incorporation of 0.4 mM apigenin and 1 mM N-acetylcysteine amide into canine semen extenders is recommended to improve preservation outcomes and potentially support better fertility rates in breeding programs. Further studies are warranted to confirm in vivo fertility and explore applications in cryopreservation and other species. Acknowledgements The authors would like to sincerely thank the members of the Faculty of Veterinary Medicine and Urmia University Research Council for the approval and support of this research. Statements We want to declare that the work described is original research that has not been published previously and is not under consideration for publication elsewhere. All the authors listed wish to be considered for publication in BMC Veterinary Research. No conflict of interest exists in submitting this manuscript; all authors have approved the paper for publication. Abbreviations Artificial Insemination Amplitude of Lateral Head Displacement Acridine Orange Adenosine Triphosphate Beat-Cross Frequency Catalase Computer-Assisted Sperm Analysis Dimethyl Sulfoxide Deoxyribonucleic Acid Ferric Reducing Ability of Plasma Glutathione Peroxidase Reduced Glutathione Hydrogen Peroxide Hypoosmotic Swelling Test Linearity Malondialdehyde Mitochondrial Membrane Potential N-Acetylcysteine Amide N-Acetyl-L-Cysteine Oxygen Consumption Rate Progressive Motility Polyunsaturated Fatty Acids Reactive Oxygen Species Standard Error of the Mean Superoxide Dismutase Straightness Total Antioxidant Capacity Total Motility Total Thiol Groups Average Path Velocity Curvilinear Velocity Straight-Line Velocity Authors’ contributions Soroush Heidari, Ali Soleimanzadeh, and Reza Mirzaie were involved in the idea, design, data collection, statistical analysis, and paper preparation. Soroush Heidari, Ali Soleimanzadeh, and Reza Mirzaie all contributed to the study’s supervision, as well as the manuscript’s drafting. The final version was accepted for submission by all writers. Funding No external funding was received for this research. Data availability This article contains all the data that were created or evaluated during the research. Declarations Ethics approval and consent to participate All of the protocols were approved by the Faculty of Veterinary Medicine’s Committee on the Ethics of Animal Experiments at Urmia University. Every procedure was carried out in accordance with the relevant laws and standards. The study was conducted in compliance with the ARRIVE standards. The owner(s) of the animals gave their informed consent for us to use them in the study. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement This article contains all the data that were created or evaluated during the research.